Clinical Trials for Neuromyelitis Optica Spectrum Disorder

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

NCT ID: NCT05909761

This clinical trial is studying the safety of a medication called UPLIZNA® in women who are pregnant or planning to become pregnant and have a condition called Neuromyelitis Optica Spectrum Disorde...

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

NCT ID: NCT05549258

This clinical trial is studying a medication called inebilizumab to see how it works in children and teenagers aged 2 to under 18 years who have a condition called neuromyelitis optica spectrum dis...

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT ID: NCT05199688

This clinical trial is studying a medication called satralizumab in children aged 2 to 11 years who have a condition known as neuromyelitis optica spectrum disorder (NMOSD). NMOSD can cause inflamm...

Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder

NCT ID: NCT06561009

This clinical trial is exploring a new treatment called BAFFR CART for patients with a condition known as Neuromyelitis Optica Spectrum Disorder (NMOSD), which can cause severe symptoms and relapse...

Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT ID: NCT06180278

This clinical trial is studying a medication called inebilizumab for people with Neuromyelitis Optica Spectrum Disorder (NMOSD), a condition that affects the nervous system. The trial aims to under...

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

NCT ID: NCT05966467

This clinical trial is studying the long-term effects of a specific treatment called Alexion C5 inhibitors in patients with a condition known as AQP4+ Neuromyelitis Optica Spectrum Disorder (NMOSD)...

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

NCT ID: NCT06374264

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

NCT ID: NCT05346354

This clinical trial is investigating a medication called ravulizumab to see how safe and effective it is for children and teenagers with Neuromyelitis Optica Spectrum Disorder (NMOSD), a rare condi...

French Registry for Monitoring Pregnancies for Multiple Sclerosis

NCT ID: NCT03900221

This clinical trial, called the French Registry for Monitoring Pregnancies for Multiple Sclerosis, is looking at how pregnancy affects women with multiple sclerosis (MS) and related conditions. The...

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

NCT ID: NCT05017142

The Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) is a study that aims to gather important information about various inflammatory brain diseases affecting children in Swit...

Biomarkers in Autoimmune Disease of Nervous System

NCT ID: NCT06502015

This clinical trial is looking at different autoimmune diseases that can affect the nervous system, such as Multiple Sclerosis, Myasthenia Gravis, and Neuromyelitis Optica Spectrum Disorder. These ...

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

NCT ID: NCT04561557

This clinical trial is studying a new treatment called CT103A cells for patients with certain autoimmune diseases that affect the nervous system. These diseases include conditions like Myasthenia G...

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

NCT ID: NCT01623076

The Longitudinal CONQUER Study is a clinical trial focused on understanding rare neuroimmunologic disorders, specifically conditions like Neuromyelitis Optica (NMO), Neuromyelitis Optica Spectrum D...

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)

NCT ID: NCT06474520

This clinical trial is investigating the potential benefits of a substance called Calculus Bovis Sativus (CBS) for patients with idiopathic inflammatory demyelinating diseases (IIDD), which include...

Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

NCT ID: NCT05891379

This clinical trial is investigating the use of a medication called inebilizumab for treating patients with acute Neuromyelitis Optica Spectrum Disorder (NMOSD). NMOSD is a condition that affects t...

FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

NCT ID: NCT06497374

This clinical trial is investigating a new treatment called efgartigimod for patients experiencing an acute attack of neuromyelitis optica spectrum disorders (NMOSD), a condition where the immune s...

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT ID: NCT04886492